- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03372005
The Effect of Floorball on Health and Performance in Subjects With Lifestyle Diseases
May 27, 2019 updated by: Morten Hostrup, PhD, University of Copenhagen
The Effect of Floorball on Health Parameters and Performance in Subjects With Lifestyle Diseases
To investigate the effect of floorball on health and performance in subjects with either type 2 diabetes or cardiovascular diseases.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
500
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Copenhagen, Denmark
- August Krogh Building
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 85 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Diagnosed with type 2 diabetes
- Diagnosed with a cardiovascular disease (bp >140/90mmHg)
- Physical activity <2 hours pr. week.
- Not participating in any regular physical activity the last 2 years
Exclusion Criteria:
- age <18 years
- Injuries that prevent the subject from playing floorball
- Type 1 diabetics
- Alcohol >14 units pr. week.
- Pregnancy
- Participation in other scientific studies
- Abuse of illegal drugs
- other known serious diseases
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Floorball
The subjects in this group are set to play floorball three times pr.
week for 39 weeks.
|
This intervention will have one week of testing before the first 12 weeks of floorball, followed by one week of testing before the last 27 week training period.
|
|
No Intervention: Control
This group functions as a control group, that will continue the normal lifestyle throughout the study.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
HbA1c
Time Frame: Changes from baseline measured after 12 weeks and 39 weeks
|
Long term blood sugar concentration
|
Changes from baseline measured after 12 weeks and 39 weeks
|
|
Blood pressure
Time Frame: Changes from baseline measured after 12 weeks and 39 weeks
|
Changes from baseline measured after 12 weeks and 39 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 12, 2017
Primary Completion (Actual)
May 27, 2019
Study Completion (Anticipated)
June 27, 2020
Study Registration Dates
First Submitted
November 17, 2017
First Submitted That Met QC Criteria
December 7, 2017
First Posted (Actual)
December 13, 2017
Study Record Updates
Last Update Posted (Actual)
May 29, 2019
Last Update Submitted That Met QC Criteria
May 27, 2019
Last Verified
May 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Floorball
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Type2 Diabetes, Cardiovascular Diseases
-
Brigham and Women's HospitalCompletedType2 Diabetes Mellitus | Atherosclerotic Cardiovascular DiseaseUnited States
-
Bangladesh Medical UniversityEnrolling by invitationType2 Diabetes MellitusBangladesh
-
Penn State UniversityThe Peanut InstituteCompleted
-
Johns Hopkins UniversityUniversity of Colorado, Denver; National Institute of Diabetes and Digestive... and other collaboratorsCompletedHypertension | Diabetes Mellitus, Type 2 | Diabetes | Diabetes type2 | Type 2 Diabetes | Type2 Diabetes | Type II Diabetes | High Blood PressureUnited States
-
University of BedfordshireWithdrawnSedentary Lifestyle | Type2 Diabetes | Cardiovascular Risk Factor
-
Chonticha KaewjohoUniversity of PhayaoCompletedType2 Diabetes Mellitus | Autonomic Nervous System ImbalanceThailand
-
Mathias Ried-LarsenCompletedDiabetes Mellitus, Type 2 | Type 2 Diabetes Mellitus | Type2 Diabetes | Type2 Diabetes MellitusDenmark
-
Groupe Hospitalier Paris Saint JosephActive, not recruiting
-
University of MichiganAstraZenecaCompletedCardiovascular Diseases | Type2 DiabetesUnited States
-
Sansum Diabetes Research InstituteEli Lilly and CompanyCompletedCardiovascular Diseases | Type2 Diabetes MellitusUnited States